Nadler, Michelle B.
Corrado, Ann Marie
Wilson, Brooke E.
Desnoyers, Alexandra
Amir, Eitan
Ivers, Noah
Desveaux, Laura
Article History
Received: 20 October 2022
Accepted: 23 January 2023
First Online: 20 February 2023
Declarations
:
: Ethics approval was obtained at Women’s College Hospital # 2019-0141-E. Informed consent was obtain from all participants.
: Not Applicable.
: Dr. Eitan Amir reports personal fees from Genentech/Roche, personal fees from Apobiologix, personal fees from Myriad Genetics, personal fees from Agendia, outside the submitted work. Dr. Michelle B. Nadler reports honoraria from an advisory board for Exact Sciences. Dr. Alexandra Desnoyers reports honoraria from advisory boards for Novartis, Pfizer, and Gilead. Dr. Brooke E. Wilson reports honoraria from an advisory board with AstraZeneca/Marck. These are all unrelated to the content of the manuscript. No Conflict of Interest for Ann Marie Corrado, Laura Desveaux and Dr. Noah M. Ivers.